tiprankstipranks
Option Care Health (MX:OPCH)
:OPCH
Mexico Market
OPCH
Option Care Health
RESEARCH TOOLSreports

Option Care Health (OPCH) Ratios

0 Followers

Option Care Health Ratios

MX:OPCH's free cash flow for Q2 2026 was $0.19. For the 2026 fiscal year, MX:OPCH's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.47 1.53 1.70 1.77 1.76
Quick Ratio
 0.98 0.96 1.20 1.33 1.36
Cash Ratio
 0.24 0.28 0.53 0.56 0.52
Solvency Ratio
 0.13 0.13 0.14 0.17 0.12
Operating Cash Flow Ratio
 0.42 0.31 0.41 0.60 0.47
Short-Term Operating Cash Flow Coverage
 51.15 38.12 49.66 15.29 10.54
Net Current Asset Value
$ -918.29M$ -864.41M$ -694.88M$ -812.43M$ -851.95M
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.37 0.36 0.35 0.36
Debt-to-Equity Ratio
 1.01 0.96 0.87 0.82 0.83
Debt-to-Capital Ratio
 0.50 0.49 0.46 0.45 0.45
Long-Term Debt-to-Capital Ratio
 0.48 0.47 0.44 0.43 0.43
Financial Leverage Ratio
 2.68 2.61 2.44 2.34 2.33
Debt Service Coverage Ratio
 5.20 4.88 4.84 4.40 3.36
Interest Coverage Ratio
 5.79 5.35 5.31 5.06 4.38
Debt to Market Cap
 0.32 0.22 0.28 0.18 0.20
Interest Debt Per Share
 8.57 8.25 7.45 6.86 6.68
Net Debt to EBITDA
 2.59 2.50 2.03 1.74 2.65
Profitability Margins
Gross Profit Margin
18.17%18.06%20.27%22.81%21.98%
EBIT Margin
6.04%6.13%6.65%9.53%6.58%
EBITDA Margin
7.29%7.38%7.93%10.98%8.24%
Operating Profit Margin
5.94%5.98%6.44%7.31%6.09%
Pretax Profit Margin
5.01%5.01%5.67%8.34%5.22%
Net Profit Margin
3.68%3.67%4.24%6.21%3.82%
Continuous Operations Profit Margin
3.68%3.67%4.24%6.21%3.82%
Net Income Per EBT
73.41%73.38%74.69%74.45%73.17%
EBT Per EBIT
84.38%83.72%88.12%114.03%85.65%
Return on Assets (ROA)
6.20%6.01%6.19%8.02%4.66%
Return on Equity (ROE)
15.83%15.65%15.08%18.79%10.86%
Return on Capital Employed (ROCE)
13.22%12.87%12.18%11.61%9.01%
Return on Invested Capital (ROIC)
9.59%9.33%9.00%8.57%6.53%
Return on Tangible Assets
11.96%11.36%11.36%18.39%11.28%
Earnings Yield
5.68%4.02%5.32%4.43%2.76%
Efficiency Ratios
Receivables Turnover
 10.37 11.93 12.20 10.00 10.30
Payables Turnover
 7.28 7.23 6.52 7.79 8.13
Inventory Turnover
 11.66 9.83 10.27 12.12 13.72
Fixed Asset Turnover
 40.55 40.58 23.37 21.01 21.82
Asset Turnover
 1.69 1.63 1.46 1.29 1.22
Working Capital Turnover Ratio
 13.45 11.55 9.82 9.51 11.61
Cash Conversion Cycle
 16.39 17.30 9.53 19.73 17.13
Days of Sales Outstanding
 35.21 30.60 29.92 36.49 35.45
Days of Inventory Outstanding
 31.31 37.15 35.55 30.11 26.60
Days of Payables Outstanding
 50.12 50.45 55.94 46.88 44.92
Operating Cycle
 66.52 67.74 65.47 66.61 62.05
Cash Flow Ratios
Operating Cash Flow Per Share
 2.24 1.59 1.88 2.07 1.48
Free Cash Flow Per Share
 2.24 1.34 1.68 1.84 1.28
CapEx Per Share
 0.00 0.25 0.21 0.23 0.20
Free Cash Flow to Operating Cash Flow
 1.00 0.84 0.89 0.89 0.87
Dividend Paid and CapEx Coverage Ratio
 0.00 6.26 9.08 8.87 7.57
Capital Expenditure Coverage Ratio
 0.00 6.26 9.08 8.87 7.57
Operating Cash Flow Coverage Ratio
 0.27 0.20 0.27 0.32 0.23
Operating Cash Flow to Sales Ratio
 0.06 0.05 0.06 0.09 0.07
Free Cash Flow Yield
9.71%4.20%7.23%5.46%4.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.93 24.89 18.86 22.58 36.20
Price-to-Sales (P/S) Ratio
 0.63 0.91 0.80 1.40 1.38
Price-to-Book (P/B) Ratio
 2.93 3.89 2.83 4.24 3.93
Price-to-Free Cash Flow (P/FCF) Ratio
 10.30 23.78 13.83 18.30 23.47
Price-to-Operating Cash Flow Ratio
 10.64 19.98 12.31 16.24 20.37
Price-to-Earnings Growth (PEG) Ratio
 3.80 6.12 -1.08 0.28 5.65
Price-to-Fair Value
 2.93 3.89 2.83 4.24 3.93
Enterprise Value Multiple
 11.19 14.89 12.08 14.51 19.42
Enterprise Value
 4.65B 6.21B 4.79B 6.85B 6.31B
EV to EBITDA
 11.19 14.89 12.08 14.51 19.42
EV to Sales
 0.82 1.10 0.96 1.59 1.60
EV to Free Cash Flow
 13.40 28.58 16.63 20.80 27.18
EV to Operating Cash Flow
 13.40 24.01 14.80 18.45 23.59
Tangible Book Value Per Share
 -2.37 -1.86 -0.89 -2.54 -2.82
Shareholders’ Equity Per Share
 8.14 8.18 8.18 7.94 7.65
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.25 0.26 0.27
Revenue Per Share
 36.78 34.85 29.13 24.04 21.78
Net Income Per Share
 1.35 1.28 1.23 1.49 0.83
Tax Burden
 0.73 0.73 0.75 0.74 0.73
Interest Burden
 0.83 0.82 0.85 0.88 0.79
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.12 0.12 0.13 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.65 1.25 1.53 1.39 1.78
Currency in USD